Principal Investigator
David Kerman
Enrollment Status
Open
Clinical Trial ID
Institutional Protocol #
20251056
Clinical Trial Summary
Sanofi-Aventis: A multicenter, multinational, randomized, double-blind, placebo-controlled Phase 3, induction study to evaluate the efficacy and safety of duvakitug in participants with moderately to severely active Ulcerative Colitis.
Phase
Phase III
Funding Agency/Sponsor
Industry
Disease
Gastrointestinal, Stomach, Esophageal
Contact Information
Study Contact
Niurka Colina
Phone Number
+1 (305) 2436405
Email
nxc610@miami.edu